Affiliation:
1. Department of Gastrointestinal Surgery, Imperial College School of Medicine, Westminster Hospital, UK
2. Department of Immunology, Imperial College School of Medicine, Chelsea and Westminster Hospital, UK
3. Department of Human Nutrition, Royal London Hospital, London, UK
Abstract
Abstract
Background
One of the difficulties in assessing the contribution of tumour-related factors to cancer cachexia is measurement of the extent of disease where dissemination to multiple organ sites has occurred.
Methods
In this study the extent of tumour (both tumour volume and increase in marker levels), diet and patient-related factors (appetite, metabolic hormones, immune activation, liver function and quality of life) were compared in patients with colorectal liver metastases who had lost at least 1 kg in body-weight (weight loss) and patients who had not lost 1 kg in body weight (stable weight) during the preceding month.
Results
Forty patients (22 men; 14 with weight loss) were studied. Liver metastasis volume was significantly greater in patients who lost weight than in those whose weight was stable (median (interquartile range) 1179 (245–1517) versus 119 (23–523) ml; P = 0·003). The prevalence of patients with raised levels of serum immune products was significantly greater in the weight loss group for soluble interleukin (IL) 2 receptor α (sIL2rα) (P = 0·03) and IL-6 (P = 0·05), but not for soluble tumour necrosis factor receptor 1 (sTNFr1) or neopterin. There were significant correlations between serum C-reactive protein and sIL2rα (rs = 0·68, P < 0·0001) and IL-6 (rs = 0·46, P = 0·008) but not sTNFr1 or neopterin levels. Significant differences in appetite, nausea, diet, energy intake, liver function tests and serum levels of metabolic hormones were not detected.
Conclusion
Weight loss in patients with colorectal liver metastases was not explained by changes in diet, quality of life, or hormones, but activation of the innate and incomplete activation of the acquired immune systems may be involved. Agents that attenuate either the acute-phase inflammatory response or T lymphocyte IL-2 receptor upregulation might reduce weight loss in patients with metastatic disease.
Publisher
Oxford University Press (OUP)
Reference36 articles.
1. Uncomplicated starvation versus cancer cachexia;Brennan;Cancer Res,1977
2. Evidence for tumour necrosis factor/cachectin production in cancer;Balkwill;Lancet,1987
3. Elevated circulating interleukin-6 is associated with an acute-phase response but reduced fixed hepatic protein synthesis in patients with cancer;Fearon;Ann Surg,1991
4. Taste and smell acuity in patients with cancer;Henkin;Fed Proc,1983
5. Cancer cachexia;Kern;JPEN J Parenter Enteral Nutr,1988
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献